TrialCancer gene therapy2006

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer.

J Nemunaitis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.